The global Hydrocolloid Dressing Market size is anticipated to reach USD 2.04 billion by 2030, registering a CAGR of 4.99% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients, and surge in research and development activities are among the major factors driving the market growth. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the general population is likely to increase the number of patients getting treatment and fuel the adoption of hydrocolloid dressings.
Furthermore,
the rising prevalence of acute wounds, such as surgical wounds and burns, is
further expected to drive the demand for hydrocolloid wound dressings
throughout the projected period. Surgical wounds, for example, are a major
problem in general healthcare, according to the Wound Healing Society (WHS).
Despite all attempts, Surgical Site Infections (SSI) cause death in 75% of
patients globally. As a result, the increased incidence of infections has
imposed a significant cost burden on the healthcare business. This is likely to
contribute to the launch of advanced products, thus fostering market growth.
Clinical uses for several hydrocolloid materials have been proposed in recent
years.
Related Press
Release@ Hydrocolloid Dressing Market Report
Hydrocolloid Dressing Market Report Highlights
- The chronic
wound application segment is estimated to dominate the market during the
forecast period
- On the basis
of end-uses, the hospital segment dominated the market in 2021. The
segment’s dominance is attributed to the increasing number of patient
admissions for wound injuries and the developing healthcare infrastructure
- North
America dominated the marketin 2021 owing to the strong presence of key
players and high healthcare expenditure
- Extensive
research is now being conducted to study the effectiveness of hydrocolloid
dressings. Companies are extensively spending on R&D and are always
working on achieving excellent clinical trial outcomes
- For
instance, in January 2021, a clinical trial, “Effect of Evidence-based
Skin Care & Hydrocolloid Dressing in the Prevention of Nasogastric-related
Pressure Injury”, was conducted, which was sponsored by MAIDE YESILYURT,
Necmettin Erbakan University
- Thus, robust
clinical studies to commercialize innovative hydrocolloid dressing
products are expected to drive the growth of the market during the projected
period
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment